Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
7.12 AUD
-0.28%
Market Closed
Updated:
May 10, 2024
Mayne Pharma Group Ltd
Other Operating Expenses
|
Mayne Pharma Group Ltd
Other Operating Expenses Peer Comparison
Comparables:
RCE
NEU
BOT
PBP
C
CU6
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Other Operating Expenses
AU$6.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Other Operating Expenses
-AU$2.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Other Operating Expenses
-AU$2m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
-42%
|
|
|
Probiotec Ltd
ASX:PBP
|
Other Operating Expenses
-AU$6.3m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-25%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Other Operating Expenses
AU$9.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Other Operating Expenses?
Other Operating Expenses
6.5m
AUD
6.5m
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Other Operating Expenses amounts to 6.5m AUD.
What is Mayne Pharma Group Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
-26%
-26%
Over the last year, the Other Operating Expenses growth was -90%. The average annual Other Operating Expenses growth rates for Mayne Pharma Group Ltd have been -26% over the past three years .
You don't have any saved screeners yet
